Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population

被引:39
|
作者
Hang, Dong [1 ]
Yin, Yin [1 ]
Han, Jing [1 ]
Jiang, Jie [1 ]
Ma, Hongxqia [1 ]
Xie, Shuanghua [2 ]
Feng, Xiaoshuang [2 ]
Zhang, Kai [3 ]
Hu, Zhibin [1 ,4 ]
Shen, Hongbing [1 ,4 ]
Clifford, Gary M. [5 ]
Dai, Min [2 ]
Li, Ni [2 ]
机构
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China
[2] Chinese Acad Med Sci, Canc Inst & Hosp, Natl Off Canc Prevent & Control, 17 Panjiayuannanli, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Canc Prevent, Beijing 100021, Peoples R China
[4] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China
[5] Int Agcy Res Canc, Infect & Canc Epidemiol, F-69372 Lyon, France
基金
中国国家自然科学基金; 中国博士后科学基金; 北京市自然科学基金;
关键词
Human papillomavirus 16; Variant; Cervical cancer; Case-control study; Meta-analysis; NATURAL VARIANTS; INTRAEPITHELIAL NEOPLASIA; TYPE-16; E6; HUMAN-PAPILLOMAVIRUS-16; WORLDWIDE; WOMEN; GENE; KERATINOCYTES; METAANALYSIS;
D O I
10.1016/j.virol.2015.11.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HPV16 is the most carcinogenic HPV type, but only a minority of HPV16 infections progress to cancer. Intratype genetic variants of HPV16 have been suggested to confer differential carcinogenicity. To investigate risk implications of HPV16 variants among Chinese women, a case-control study was conducted with 298 cervical cancer patients and 85 controls (all HPV16-positive). HPV16 isolates were predominantly of the A variant lineage, and variants of A4 (previously named "Asian") sublineage were common. A4/Asian variants were significantly associated with increased risk of cervical cancer compared to A1-3 (OR=1.72, 95% CI=1.04-2.85). Furthermore, a meta-analysis including 703 cases and 323 controls from East Asia confirmed the association (OR=2.82, 95% CI=1.44-5.52). In conclusion, A4 variants appear to predict higher risk of cervical cancer among HPV16-positive women, which may provide clues to the genetic basis of differences in the carcinogenicity of HPV16 variants. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 50 条
  • [11] Human papillomavirus infection and the risk of cervical cancer in Japan
    Matsumoto, Koji
    Yoshikawa, Hiroyuki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (01) : 7 - 17
  • [12] Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia
    Bokal, Eda Vrtacnik
    Kocjan, Bostjan J.
    Poljak, Mario
    Bogovac, Zeljka
    Jancar, Nina
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (06) : 1204 - 1213
  • [13] Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population
    Zhou, Ziyun
    Yang, Hongying
    Yang, Lijuan
    Yao, Yueting
    Dai, Shuying
    Shi, Li
    Li, Chuanyin
    Yang, Longyu
    Yan, Zhiling
    Yao, Yufeng
    INFECTION GENETICS AND EVOLUTION, 2019, 73 : 13 - 20
  • [14] Human papillomavirus and cervical cancer
    Okunade, Kehinde Sharafadeen
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019,
  • [15] Human papillomavirus and cervical cancer
    Okunade, Kehinde Sharafadeen
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 40 (05) : 602 - 608
  • [16] Prevalence of Human Papillomavirus 16 in Esophageal Cancer Among the Chinese Population: a Systematic Review and Meta-analysis
    Zhang, Shao-Kai
    Guo, Lan-Wei
    Chen, Qiong
    Zhang, Meng
    Liu, Shu-Zheng
    Quan, Pei-Liang
    Lu, Jian-Bang
    Sun, Xi-Bin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (23) : 10143 - 10149
  • [17] High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population
    Zhao, Xue-Lian
    Hu, Shang-Ying
    Zhang, Qian
    Dong, Li
    Feng, Rui-Mei
    Han, Ross
    Zhao, Fang-Hui
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (04)
  • [18] Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France
    Heard, Isabelle
    Tondeur, Laura
    Arowas, Laurence
    Res, Michael Falguie
    Demazoin, Marie-Christine
    Favre, Michel
    PLOS ONE, 2013, 8 (11):
  • [19] Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
    Arbyn, Marc
    Ronco, Guglielmo
    Anttila, Ahti
    Meijer, Chris J. L. M.
    Poljak, Mario
    Ogilvie, Gina
    Koliopoulos, George
    Naucler, Pontus
    Sankaranarayanan, Rengaswamy
    Peto, Julian
    VACCINE, 2012, 30 : F88 - F99
  • [20] The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer
    Richard, C.
    Lanner, C.
    Naryzhny, S. N.
    Sherman, L.
    Lee, H.
    Lambert, P. F.
    Zehbe, I.
    ONCOGENE, 2010, 29 (23) : 3435 - 3445